Published in Synapse on January 01, 2001
Salvinicins A and B, new neoclerodane diterpenes from Salvia divinorum. Org Lett (2005) 1.23
Herkinorin analogues with differential beta-arrestin-2 interactions. J Med Chem (2008) 1.03
Potential Drug Abuse Therapeutics Derived from the Hallucinogenic Natural Product Salvinorin A. Medchemcomm (2011) 0.97
Probes for narcotic receptor mediated phenomena. 39. Enantiomeric N-substituted benzofuro[2,3-c]pyridin-6-ols: synthesis and topological relationship to oxide-bridged phenylmorphans. J Med Chem (2009) 0.96
Probes for narcotic receptor mediated phenomena. 44. Synthesis of an N-substituted 4-hydroxy-5-(3-hydroxyphenyl)morphan with high affinity and selective μ-antagonist activity. Eur J Med Chem (2012) 0.96
Probes for narcotic receptor mediated phenomena. 46. N-substituted-2,3,4,9,10,10a-hexahydro-1H-1,4a-(epiminoethano)phenanthren-6- and 8-ols - carbocyclic relatives of f-oxide-bridged phenylmorphans. Eur J Med Chem (2012) 0.90
Differential effects of opioid agonists on G protein expression in CHO cells expressing cloned human opioid receptors. Brain Res Bull (2008) 0.88
Probes for narcotic receptor mediated phenomena. 41. Unusual inverse μ-agonists and potent μ-opioid antagonists by modification of the N-substituent in enantiomeric 5-(3-hydroxyphenyl)morphans. J Med Chem (2011) 0.83
Probes for narcotic receptor mediated phenomena. 43. Synthesis of the ortho-a and para-a, and improved synthesis and optical resolution of the ortho-b and para-b oxide-bridged phenylmorphans: compounds with moderate to low opioid-receptor affinity. Bioorg Med Chem (2011) 0.83
Probes for narcotic receptor mediated phenomena. 47. Novel C4a- and N-substituted-1,2,3,4,4a,9a-hexahydrobenzofuro[2,3-c]pyridin-6-ols. Bioorg Med Chem (2013) 0.80
Probes for narcotic receptor mediated phenomena 49. N-substituted rac-cis-4a-arylalkyl-1,2,3,4,4a,9a-hexahydrobenzofuro[2,3-c]pyridin-6-ols. Eur J Med Chem (2015) 0.75
A motif-based profile scanning approach for genome-wide prediction of signaling pathways. Nat Biotechnol (2001) 6.50
Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci (1991) 5.88
Cannabinoid receptor localization in brain. Proc Natl Acad Sci U S A (1990) 5.48
High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R. J Biol Chem (2000) 5.18
Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse (2001) 4.03
The Drosophila single-minded gene encodes a nuclear protein with sequence similarity to the per gene product. Cell (1988) 3.06
Potent and nontoxic antisense oligonucleotides containing locked nucleic acids. Proc Natl Acad Sci U S A (2000) 3.04
A proposal for the classification of sigma binding sites. Trends Pharmacol Sci (1992) 2.65
A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria. Infect Immun (1996) 2.60
Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities. J Pharmacol Exp Ther (1993) 2.40
Sigma receptors: biology and function. Pharmacol Rev (1990) 2.37
Comparison of bolus and infusion methods for receptor quantitation: application to [18F]cyclofoxy and positron emission tomography. J Cereb Blood Flow Metab (1993) 2.28
Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. Proc Natl Acad Sci U S A (2000) 2.19
From grasshopper to Drosophila: a common plan for neuronal development. Nature (1984) 2.09
An opioid agonist that does not induce mu-opioid receptor--arrestin interactions or receptor internalization. Mol Pharmacol (2006) 2.06
Mechanisms of opioid-induced pain and antinociceptive tolerance: descending facilitation and spinal dynorphin. Pain (2001) 2.05
PCR detection of DNA specific for Aspergillus species in serum of patients with invasive aspergillosis. J Clin Microbiol (1996) 1.97
Distinct potassium channels on pain-sensing neurons. Proc Natl Acad Sci U S A (2001) 1.90
Mutations altering synaptic connectivity between identified neurons in Drosophila. J Neurosci (1984) 1.87
Pathogenicity of minute virus of canines (MVC) for the canine fetus. Cornell Vet (1991) 1.80
Functional comparison of D-serine and glycine in rodents: the effect on cloned NMDA receptors and the extracellular concentration. J Neurochem (1995) 1.79
Cell recognition during neuronal development. Science (1984) 1.77
Stereospecific and nonstereospecific effects of (+)- and (-)-morphine: evidence for a new class of receptors? Science (1977) 1.77
Tonic descending facilitation from the rostral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance. J Neurosci (2001) 1.76
Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus. Neuropsychopharmacology (2000) 1.72
Inhibition of neuropathic pain by selective ablation of brainstem medullary cells expressing the mu-opioid receptor. J Neurosci (2001) 1.72
Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance. J Neurosci (2000) 1.71
Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs. J Pharmacol Exp Ther (2005) 1.70
Primary structure of rat cardiac beta-adrenergic and muscarinic cholinergic receptors obtained by automated DNA sequence analysis: further evidence for a multigene family. Proc Natl Acad Sci U S A (1987) 1.70
Axon routing across the midline controlled by the Drosophila Derailed receptor. Nature (1999) 1.70
Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates. Proc Natl Acad Sci U S A (2000) 1.69
Pronociceptive actions of dynorphin maintain chronic neuropathic pain. J Neurosci (2001) 1.67
A LIM-homeodomain combinatorial code for motor-neuron pathway selection. Nature (1999) 1.66
A comparison of the potential role of the tetrodotoxin-insensitive sodium channels, PN3/SNS and NaN/SNS2, in rat models of chronic pain. Proc Natl Acad Sci U S A (1999) 1.66
Generation of a humanized, high affinity anti-tissue factor antibody for use as a novel antithrombotic therapeutic. Thromb Haemost (2001) 1.64
A double-blind, placebo-controlled study of the use of amphetamine in the treatment of aphasia. Stroke (2001) 1.61
Inducible expression of claudin-1-myc but not occludin-VSV-G results in aberrant tight junction strand formation in MDCK cells. J Cell Sci (2000) 1.58
In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation. Endocrinology (1996) 1.57
Minute virus of canines (MVC, canine parvovirus type-1): pathogenicity for pups and seroprevalence estimate. J Vet Diagn Invest (1994) 1.56
Opioid activation of toll-like receptor 4 contributes to drug reinforcement. J Neurosci (2012) 1.55
Identification of the first trans-(3R,4R)- dimethyl-4-(3-hydroxyphenyl)piperidine derivative to possess highly potent and selective opioid kappa receptor antagonist activity. J Med Chem (2001) 1.54
A faster-acting and more potent form of tissue plasminogen activator. Proc Natl Acad Sci U S A (1994) 1.52
Tau-beta-galactosidase, an axon-targeted fusion protein. Proc Natl Acad Sci U S A (1994) 1.52
The Drosophila islet gene governs axon pathfinding and neurotransmitter identity. Neuron (1997) 1.50
Monoamine releasers with varying selectivity for dopamine/norepinephrine versus serotonin release as candidate "agonist" medications for cocaine dependence: studies in assays of cocaine discrimination and cocaine self-administration in rhesus monkeys. J Pharmacol Exp Ther (2006) 1.50
Operation for type A aortic dissection: introduction of retrograde cerebral perfusion. Ann Thorac Surg (1995) 1.47
Apterous is a Drosophila LIM domain gene required for the development of a subset of embryonic muscles. Neuron (1992) 1.46
Page kidney in a hemodialyzed patient. Nephron (1996) 1.46
Hypothesis that mesolimbic dopamine (DA) plays a key role in mediating the reinforcing effects of drugs of abuse as well as the rewarding effects of ingestive behaviors. J Subst Abuse Treat (1994) 1.45
Lack of involvement of capsaicin-sensitive primary afferents in nerve-ligation injury induced tactile allodynia in rats. Pain (1999) 1.43
Studies in the (+)-morphinan series. 5. Synthesis and biological properties of (+)-naloxone. J Med Chem (1978) 1.43
Control of neuronal pathway selection by the Drosophila LIM homeodomain gene apterous. Development (1995) 1.42
Effects of murine-derived anti-methamphetamine monoclonal antibodies on (+)-methamphetamine self-administration in the rat. J Pharmacol Exp Ther (2004) 1.42
Comparison of magnetic resonance imaging-fluorodeoxy- glucose positron emission tomography fusion with pathological staging in rectal cancer. Br J Surg (2010) 1.41
Descending facilitation from the rostral ventromedial medulla maintains nerve injury-induced central sensitization. Neuroscience (2006) 1.39
The role of apterous in the control of dorsoventral compartmentalization and PS integrin gene expression in the developing wing of Drosophila. Development (1994) 1.37
Rapid reduction of MDCK cell cholesterol by methyl-beta-cyclodextrin alters steady state transepithelial electrical resistance. Eur J Cell Biol (1999) 1.37
Glial cell line-derived neurotrophic factor normalizes neurochemical changes in injured dorsal root ganglion neurons and prevents the expression of experimental neuropathic pain. Neuroscience (2003) 1.35
Regulation of the phospholipase C-gamma2 pathway in B cells. Immunol Rev (2000) 1.34
A comparison of measured and calculated free 25(OH) vitamin D levels in clinical populations. J Clin Endocrinol Metab (2014) 1.34
Evidence that intrathecal morphine-3-glucuronide may cause pain enhancement via toll-like receptor 4/MD-2 and interleukin-1beta. Neuroscience (2010) 1.33
Spinal and supraspinal mechanisms of neuropathic pain. Ann N Y Acad Sci (2000) 1.33
The Drosophila bendless gene encodes a neural protein related to ubiquitin-conjugating enzymes. Neuron (1993) 1.33
Isolation and characterization of Dek, a Drosophila eph receptor protein tyrosine kinase. Mol Cell Neurosci (1999) 1.32
The evaluation of subatmospheric pressure and hyperbaric oxygen in ischemic full-thickness wound healing. Am Surg (2000) 1.31
Inhibition of Photosynthesis in Some Algae by Extreme-Red Light. Science (1960) 1.31
Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans. J Med Chem (1999) 1.31
SNC 80, a selective, nonpeptidic and systemically active opioid delta agonist. J Pharmacol Exp Ther (1995) 1.30
Preferential increases in nucleus accumbens dopamine after systemic cocaine administration are caused by unique characteristics of dopamine neurotransmission. J Neurosci (2001) 1.30
Chip and apterous physically interact to form a functional complex during Drosophila development. Mol Cell (1999) 1.30
Selective recruitment of CCR6-expressing cells by increased production of MIP-3 alpha in rheumatoid arthritis. Clin Exp Immunol (2001) 1.30
Spinal or systemic TY005, a peptidic opioid agonist/neurokinin 1 antagonist, attenuates pain with reduced tolerance. Br J Pharmacol (2010) 1.30
Opioid receptor types and subtypes: the delta receptor as a model. Annu Rev Pharmacol Toxicol (1996) 1.28
Efferent connections of the rostral portion of medial agranular cortex in rats. Brain Res Bull (1987) 1.26
Generation of anti-(+)methamphetamine antibodies is not impeded by (+)methamphetamine administration during active immunization of rats. Int Immunopharmacol (2001) 1.26
Extraterritorial neuropathic pain correlates with multisegmental elevation of spinal dynorphin in nerve-injured rats. Pain (2000) 1.25
HPK1 is activated by lymphocyte antigen receptors and negatively regulates AP-1. Immunity (2000) 1.25
Role of the inositol phosphatase SHIP in B cell receptor-induced Ca2+ oscillatory response. J Immunol (1998) 1.24
Design of novel peptide ligands which have opioid agonist activity and CCK antagonist activity for the treatment of pain. Life Sci (2003) 1.24
Supraspinal cholecystokinin may drive tonic descending facilitation mechanisms to maintain neuropathic pain in the rat. Pain (2000) 1.23
Optical isomers of aryl-2-piperidylmethanol antimalarial agents. Preparation, optical purity, and absolute stereochemistry. J Med Chem (1974) 1.23
Tolerance to 3,4-methylenedioxymethamphetamine in rats exposed to single high-dose binges. Neuroscience (2008) 1.22
Possible involvement of toll-like receptor 4/myeloid differentiation factor-2 activity of opioid inactive isomers causes spinal proinflammation and related behavioral consequences. Neuroscience (2010) 1.22
Inhibition of Photosynthesis in Certain Algae by Extreme Red Light. Biophys J (1960) 1.22
Presence and formation of codeine and morphine in the rat. Proc Natl Acad Sci U S A (1986) 1.20
Blockade of the serotonin 5-HT2A receptor suppresses cue-evoked reinstatement of cocaine-seeking behavior in a rat self-administration model. Behav Neurosci (2009) 1.20
Evaluation of PCR for detection of DNA specific for Aspergillus species in sera of patients with various forms of pulmonary aspergillosis. J Clin Microbiol (1998) 1.19
A multiple alignment algorithm for metabolic pathway analysis using enzyme hierarchy. Proc Int Conf Intell Syst Mol Biol (2000) 1.19
Structurally distinct nicotine immunogens elicit antibodies with non-overlapping specificities. Biochem Pharmacol (2011) 1.18
Three-dimensional visualization of microvessel architecture of whole-mount tissue by confocal microscopy. Microvasc Res (2006) 1.18
CCR2 regulates monocyte recruitment as well as CD4 T1 allorecognition after lung transplantation. Am J Transplant (2010) 1.17